reviewCell Death and DiseaseNov 18, 2022GOLD OA

Mutant p53 in cancer: from molecular mechanism to therapeutic modulation

Chinese Academy of Sciences · Ji Hua Laboratory · +5 more institutions

PubMed
Indexed incrossrefdoajpubmed

Abstract

TP53, a crucial tumor suppressor gene, is the most commonly mutated gene in human cancers. Aside from losing its tumor suppressor function, mutant p53 (mutp53) often acquires inherent, novel oncogenic functions, which is termed "gain-of-function". Emerging evidence suggests that mutp53 is highly associated with advanced malignancies and poor prognosis, which makes it a target for development of novel cancer therapies. Herein, we provide a summary of our knowledge of the mutp53 types and mutp53 spectrum in cancers. The mechanisms of mutp53 accumulation and gain-of-function are also summarized. Furthermore, we discuss the gain-of-function of mutp53 in cancers: genetic instability, ferroptosis, microenvironment,…

No related works found for this paper.

Funding